Case Studies

Grow

Developing a Market Strategy for a Drug Discovery and Clinical Diagnostics Platform
Boston Healthcare worked with this emerging analytical platform company to assess the market opportunity in the US in the preclinical and clinical diagnostics markets. Issues examined included market segment trends, market potential by segment, service/business models, competitor profiles, pricing, and the complex and changing environment for reimbursement and coding for genetic testing.

Market Opportunity Assessment and Valuation Modeling
Boston Healthcare has worked with both established and emerging companies to assess the market opportunity for novel specialty drugs. These engagements typically examine everything from market potential, to likely reimbursement milestones, adoption curve modeling, and product forecasts. Detailed primary research is often conducted with a mix of opinion leaders and community practice physicians depending upon stage of development. Boston Healthcare also offers real options and discounted cash flow valuation modeling, often to support business development transactions.

Portfolio Growth Strategy for Wound Care Technologies
Boston Healthcare worked with a global wound care company to examine its entire product and technology portfolio and the market in which its products compete. The assignment involved identifying market drivers and a detailed analysis of the competitive landscape and pipeline, pricing pressures, reimbursement, contracting, and competitor marketing and sales structures. Issues addressed included a gap analysis of the client’s portfolio and its licensing strategy to identify and acquire new technologies.

IVD Business Development Strategy
An IVD company with a novel cardiac risk marker needs to identify the critical path to achieve maximum value based on optimal business partnering and reimbursement pathways. Boston Healthcare is engaged to identify benchmarks that are critical for maximum success and to identify risks and rewards for different partnering models. Boston Healthcare uses primary and secondary research with blinded technology profile and discussion guides to assist in testing various business models with key stakeholders. Boston Healthcare constructs laboratory payer mix model which estimates the average reimbursement and profit expectations for various laboratory markets. Boston Healthcare analyzes the difference in implementation support needs based on various partnering options and finds coding application, cost impact modeling, lab partner support, and payer engagement to drive necessary coverage.